LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy
ICM-URC2016/27
Phase 2 other active
Quick answer
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy for Colon cancer is a Phase 2 program (other) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Colon cancer
- Phase
- Phase 2
- Modality
- other
- Status
- active